12:00 AM
 | 
Mar 22, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

SpectRx Inc regulatory update

The FDA granted 510(k) marketing clearance for

Read the full 24 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >